Session Information

Filter Results:

Show Only CME Accredited Sessions

  • +

    OA07 - Oligometastasis: What Should Be the State-Of-The-Art?

    • 15:15 - 16:45
    • 9/24/2018
    • Location: Room 107
    • Type: Oral Abstract Session
    • Track: Oligometastatic NSCLC
    • +

      OA07.05 - Local Ablative Therapy Improves Survival in Patients with Synchronous Oligometastatic NSCLC Harboring EGFR Mutation Treated with EGFR-TKIs

      16:00 - 16:10  |  Presenter: Yaping Xu  |  Author(s): Qinghua Xu, Fei Zhou, Hui Liu, Caicun Zhou

      • Abstract

      Loading...

  • +

    P1.13 - Targeted Therapy (Not CME Accredited Session)

    • 16:45 - 18:00
    • 9/24/2018
    • Location: Exhibit Hall
    • Type: Poster Viewing in the Exhibit Hall
    • Track:
    • +

      P1.13-26 - First-Line Continual EGFR-TKI Plus LAT Demonstrated Survival Benefit in Egfr-Mutant Nsclc Patients with Oligoprogressive Disease

      16:45 - 18:00  |  Presenter: Qinghua Xu  |  Author(s): Hui Liu, Tao Jiang, Shengxiang Ren, Caicun Zhou

      • Abstract

      Loading...

  • +

    P1.16 - Treatment of Early Stage/Localized Disease (Not CME Accredited Session)

    • 16:45 - 18:00
    • 9/24/2018
    • Location: Exhibit Hall
    • Type: Poster Viewing in the Exhibit Hall
    • Track:
  • +

    P2.04 - Immunooncology (Not CME Accredited Session)

    • 16:45 - 18:00
    • 9/25/2018
    • Location: Exhibit Hall
    • Type: Poster Viewing in the Exhibit Hall
    • Track: